A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma

por Labarriere, N., Fortun, A., Bellec, A., Khammari, A., Dreno, B., Saïagh, S., Lang, F.
Publicado 2013

PD-1 expression conditions T cell avidity within an antigen-specific repertoire

por Simon, Sylvain, Vignard, Virginie, Florenceau, Laetitia, Dreno, B., Khammari, A., Lang, F., Labarriere, N.
Publicado 2015

Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes

por Marotte, L, Capitao, M, Deleine, C, Beauvais, T, Cadiou, G, Perrin, J., Chérel, M, Scotet, E, Guilloux, Y, Bruchertseifer, F, Morgenstern, A, Jarry, A, Gaschet, J., Labarriere, N
Publicado 2021

Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology

por Foulon, M., Robbe-Saule, M., Manry, J., Esnault, L., Boucaud, Y., Alcaïs, A., Malloci, M., Fanton d’Andon, M., Beauvais, T., Labarriere, N., Jeannin, P., Abel, L., Saint-André, J. P., Croué, A., Delneste, Y., Boneca, I. G., Marsollier, L., Marion, E.
Publicado 2020